As 2018 signals the end of the patent cliff and branded generics face tougher competition from nonbranded manufacturers, companies are diversifying their portfolios and focusing on innovation to ensure long-term viability.
Cara Latham
Advertisement
Articles by Cara Latham
Advertisement
Latest Updated Articles
- Generics Outlook: Turning to Innovation After the Patent Cliff
Published: July 23rd 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Experts Highlight Key Sessions and Emerging Topics from The Menopause Society 2025 Annual Meeting
5
